Literature DB >> 32180085

HOTAIRM1, an enhancer lncRNA, promotes glioma proliferation by regulating long-range chromatin interactions within HOXA cluster genes.

Tengfei Shi1, Dianhao Guo1, Heming Xu1, Guangsong Su1, Jun Chen1, Zhongfang Zhao1, Jiandang Shi1, Michelle Wedemeyer2, Frank Attenello2, Lei Zhang3, Wange Lu4.   

Abstract

The long noncoding RNA HOTAIRM1 reportedly plays important roles in acute myeloid leukemia, gastric cancer and colorectal cancer. Here, we analyzed potential function of HOTAIRM1 in glioma and asked whether it participates in long-range chromatin interactions. We monitored expression of HOTAIRM1 in glioma tissues and correlated levels with patient survival using the TCGA dataset. HOTAIRM1 was highly expressed in glioma tissue, with high levels associated with shortened patient survival time. We then suppressed HOTAIRM1 activity in the human glioblastoma U251 line using CRISPR-cas9 to knock in a truncating polyA fragment. Reporter analysis of these and control cells confirmed that the HOTAIRM1 locus serves as an active enhancer. We then performed Capture-C analysis to identify target genes of that locus and applied RNA antisense purification to assess chromatin interactions between the HOTAIRM1 locus and HOXA cluster genes. HOTAIRM1 knockdown in glioma cells decreased proliferation and reduced expression of HOXA cluster genes. HOTAIRM1 regulates long-range interactions between the HOTAIRM1 locus and HOXA genes. Our work suggests a new mechanism by which HOTAIRM1 regulates glioma progression by regulating high-order chromatin structure and could suggest novel therapeutic targets to treat an intractable cancer.

Entities:  

Keywords:  Enhancer lncRNA; Glioma; HOTAIRM1; HOXA cluster genes; Long-range chromatin interaction

Mesh:

Substances:

Year:  2020        PMID: 32180085     DOI: 10.1007/s11033-020-05371-0

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  56 in total

1.  Coding-independent regulation of the tumor suppressor PTEN by competing endogenous mRNAs.

Authors:  Yvonne Tay; Lev Kats; Leonardo Salmena; Dror Weiss; Shen Mynn Tan; Ugo Ala; Florian Karreth; Laura Poliseno; Paolo Provero; Ferdinando Di Cunto; Judy Lieberman; Isidore Rigoutsos; Pier Paolo Pandolfi
Journal:  Cell       Date:  2011-10-14       Impact factor: 41.582

2.  mTORC1 and muscle regeneration are regulated by the LINC00961-encoded SPAR polypeptide.

Authors:  Akinobu Matsumoto; Alessandra Pasut; Masaki Matsumoto; Riu Yamashita; Jacqueline Fung; Emanuele Monteleone; Alan Saghatelian; Keiichi I Nakayama; John G Clohessy; Pier Paolo Pandolfi
Journal:  Nature       Date:  2016-12-26       Impact factor: 49.962

3.  A large intergenic noncoding RNA induced by p53 mediates global gene repression in the p53 response.

Authors:  Maite Huarte; Mitchell Guttman; David Feldser; Manuel Garber; Magdalena J Koziol; Daniela Kenzelmann-Broz; Ahmad M Khalil; Or Zuk; Ido Amit; Michal Rabani; Laura D Attardi; Aviv Regev; Eric S Lander; Tyler Jacks; John L Rinn
Journal:  Cell       Date:  2010-08-06       Impact factor: 41.582

4.  A Linc1405/Eomes Complex Promotes Cardiac Mesoderm Specification and Cardiogenesis.

Authors:  Xudong Guo; Yanxin Xu; Zikang Wang; Yukang Wu; Jiayu Chen; Guiying Wang; Chenqi Lu; Wenwen Jia; Jiajie Xi; Songcheng Zhu; Zeyidan Jiapaer; Xiaoping Wan; Zhongmin Liu; Shaorong Gao; Jiuhong Kang
Journal:  Cell Stem Cell       Date:  2018-05-10       Impact factor: 24.633

5.  A long noncoding RNA controls muscle differentiation by functioning as a competing endogenous RNA.

Authors:  Marcella Cesana; Davide Cacchiarelli; Ivano Legnini; Tiziana Santini; Olga Sthandier; Mauro Chinappi; Anna Tramontano; Irene Bozzoni
Journal:  Cell       Date:  2011-10-14       Impact factor: 41.582

6.  The lincRNA HOTAIRM1, located in the HOXA genomic region, is expressed in acute myeloid leukemia, impacts prognosis in patients in the intermediate-risk cytogenetic category, and is associated with a distinctive microRNA signature.

Authors:  Marina Díaz-Beyá; Salut Brunet; Josep Nomdedéu; Marta Pratcorona; Anna Cordeiro; David Gallardo; Lourdes Escoda; Mar Tormo; Inmaculada Heras; Josep Maria Ribera; Rafael Duarte; María Paz Queipo de Llano; Joan Bargay; Antonia Sampol; Meritxell Nomdedeu; Ruth M Risueño; Montserrat Hoyos; Jorge Sierra; Mariano Monzo; Alfons Navarro; Jordi Esteve
Journal:  Oncotarget       Date:  2015-10-13

7.  HOXA1 binds RBCK1/HOIL-1 and TRAF2 and modulates the TNF/NF-κB pathway in a transcription-independent manner.

Authors:  Arnaud Taminiau; Amandine Draime; Janne Tys; Barbara Lambert; Julie Vandeputte; Nathan Nguyen; Patricia Renard; Dirk Geerts; René Rezsöhazy
Journal:  Nucleic Acids Res       Date:  2016-07-05       Impact factor: 16.971

Review 8.  Potential Epigenetic-Based Therapeutic Targets for Glioma.

Authors:  Lanlan Zang; Shukkoor Muhammed Kondengaden; Fengyuan Che; Lijuan Wang; Xueyuan Heng
Journal:  Front Mol Neurosci       Date:  2018-11-15       Impact factor: 5.639

9.  Human colorectal cancer-specific CCAT1-L lncRNA regulates long-range chromatin interactions at the MYC locus.

Authors:  Jian-Feng Xiang; Qing-Fei Yin; Tian Chen; Yang Zhang; Xiao-Ou Zhang; Zheng Wu; Shaofeng Zhang; Hai-Bin Wang; Junhui Ge; Xuhua Lu; Li Yang; Ling-Ling Chen
Journal:  Cell Res       Date:  2014-03-25       Impact factor: 25.617

Review 10.  Insights about genome function from spatial organization of the genome.

Authors:  Shuvra Shekhar Roy; Ananda Kishore Mukherjee; Shantanu Chowdhury
Journal:  Hum Genomics       Date:  2018-02-20       Impact factor: 4.639

View more
  13 in total

1.  LINC02381-ceRNA exerts its oncogenic effect through regulation of IGF1R signaling pathway in glioma.

Authors:  Hossein Nemati; Masoumeh Fakhre-Taha; Amir-Reza Javanmard; Amin Jahanbakhshi; Seyed Javad Mowla; Bahram M Soltani
Journal:  J Neurooncol       Date:  2022-04-23       Impact factor: 4.130

Review 2.  There and Back Again: Hox Clusters Use Both DNA Strands.

Authors:  Elena L Novikova; Milana A Kulakova
Journal:  J Dev Biol       Date:  2021-07-15

Review 3.  MicroRNAs and Their Influence on the ZEB Family: Mechanistic Aspects and Therapeutic Applications in Cancer Therapy.

Authors:  Milad Ashrafizadeh; Hui Li Ang; Ebrahim Rahmani Moghadam; Shima Mohammadi; Vahideh Zarrin; Kiavash Hushmandi; Saeed Samarghandian; Ali Zarrabi; Masoud Najafi; Reza Mohammadinejad; Alan Prem Kumar
Journal:  Biomolecules       Date:  2020-07-12

Review 4.  Bioinformatic Tools for the Analysis and Prediction of ncRNA Interactions.

Authors:  Andrés Rincón-Riveros; Duvan Morales; Josefa Antonia Rodríguez; Victoria E Villegas; Liliana López-Kleine
Journal:  Int J Mol Sci       Date:  2021-10-22       Impact factor: 5.923

5.  Insight Into Pituitary lncRNA and mRNA at Two Estrous Stages in Small Tail Han Sheep With Different FecB Genotypes.

Authors:  Si Chen; Xiaofei Guo; Xiaoyun He; Ran Di; Xiaosheng Zhang; Jinlong Zhang; Xiangyu Wang; Mingxing Chu
Journal:  Front Endocrinol (Lausanne)       Date:  2022-02-01       Impact factor: 5.555

Review 6.  Friends with Benefits: Chemokines, Glioblastoma-Associated Microglia/Macrophages, and Tumor Microenvironment.

Authors:  Elena Codrici; Ionela-Daniela Popescu; Cristiana Tanase; Ana-Maria Enciu
Journal:  Int J Mol Sci       Date:  2022-02-24       Impact factor: 5.923

Review 7.  Exploring the Roles of lncRNAs in GBM Pathophysiology and Their Therapeutic Potential.

Authors:  Christian T Stackhouse; G Yancey Gillespie; Christopher D Willey
Journal:  Cells       Date:  2020-10-28       Impact factor: 6.600

Review 8.  Noncoding RNAs in Glioblastoma: Emerging Biological Concepts and Potential Therapeutic Implications.

Authors:  Uswa Shahzad; Stacey Krumholtz; James T Rutka; Sunit Das
Journal:  Cancers (Basel)       Date:  2021-03-28       Impact factor: 6.639

Review 9.  Long, Noncoding RNA Dysregulation in Glioblastoma.

Authors:  Patrick A DeSouza; Xuan Qu; Hao Chen; Bhuvic Patel; Christopher A Maher; Albert H Kim
Journal:  Cancers (Basel)       Date:  2021-03-31       Impact factor: 6.639

10.  The long non-coding RNA HOTAIRM1 promotes tumor aggressiveness and radiotherapy resistance in glioblastoma.

Authors:  Ulvi Ahmadov; Daniel Picard; Jasmin Bartl; Manuela Silginer; Marija Trajkovic-Arsic; Nan Qin; Lena Blümel; Marietta Wolter; Jonathan K M Lim; David Pauck; Alina Marie Winkelkotte; Marlen Melcher; Maike Langini; Viktoria Marquardt; Felix Sander; Anja Stefanski; Sascha Steltgens; Christina Hassiepen; Anna Kaufhold; Frauke-Dorothee Meyer; Annette Seibt; Lara Kleinesudeik; Anika Hain; Carsten Münk; Christiane Brigitte Knobbe-Thomsen; Alexander Schramm; Ute Fischer; Gabriel Leprivier; Kai Stühler; Simone Fulda; Jens T Siveke; Felix Distelmaier; Arndt Borkhardt; Michael Weller; Patrick Roth; Guido Reifenberger; Marc Remke
Journal:  Cell Death Dis       Date:  2021-09-28       Impact factor: 8.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.